These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7034388)

  • 1. [Domperidone affects the interdigestive motility in the jejunum (author's transl)].
    Richter A; Erckenbrecht J; Wienbeck M
    Z Gastroenterol; 1981 Dec; 19(12):767-71. PubMed ID: 7034388
    [No Abstract]   [Full Text] [Related]  

  • 2. Human antroduodenal motility, pyloric closure, and domperidone.
    Eyre-Brook IA; Smallwood R; Johnson AG
    Scand J Gastroenterol Suppl; 1984; 92():4-7. PubMed ID: 6588533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of sympathicolysis on interdigestive small bowel motility (author's transl)].
    Rampelberg F; Erckenbrecht J; Berges W; Wienbeck M
    Leber Magen Darm; 1982 Feb; 12(1):8-10. PubMed ID: 7070194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of rectosigmoid motility: action of domperidone.
    Wiley J; Owyang C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):548-51. PubMed ID: 3612550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Domperidone stimulating antral and duodenal motility in a double-blind crossover study].
    Weihrauch TR; Ehl W; Ewe K; Förster CF
    Verh Dtsch Ges Inn Med; 1978; (84):994-7. PubMed ID: 369215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of dopamine D2 receptor antagonists on gastrointestinal motility].
    Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):65-9. PubMed ID: 2273688
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetic drug Motilium: pharmacological properties and potential clinical use].
    Sheptulin AA
    Klin Med (Mosk); 1997; 75(11):48-50. PubMed ID: 9490358
    [No Abstract]   [Full Text] [Related]  

  • 9. Making a case for domperidone in the treatment of gastrointestinal motility disorders.
    Ahmad N; Keith-Ferris J; Gooden E; Abell T
    Curr Opin Pharmacol; 2006 Dec; 6(6):571-6. PubMed ID: 16997628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of domperidone in the prevention of nausea and vomiting during post-operative recovery period from anesthesia--a double blind study (author's transl)].
    Minobe T; Sekine H; Torii T; Fujiya T; Ohtomo Y
    Masui; 1981 Dec; 30(12):1380-7. PubMed ID: 7050458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of domperidone on gastric movement and blood flow in dog (author's transl)].
    Fujii K; Takasugi S
    Nihon Heikatsukin Gakkai Zasshi; 1980 Mar; 16(1):37-46. PubMed ID: 7277931
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro evaluation of the effects of domperidone on the gastrointestinal tract of healthy horses.
    Nieto JE; Maher O; Stanley SD; Larson R; Snyder JR
    Am J Vet Res; 2013 Aug; 74(8):1103-10. PubMed ID: 23879848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a new gastrokinetic drug on gastrointestinal motility: domperidone, a peripheral antidopaminergic drug].
    Chevrel B
    Med Chir Dig; 1981; 10(2):175-8. PubMed ID: 7230953
    [No Abstract]   [Full Text] [Related]  

  • 14. Domperidone in reflux oesophagitis and gastric stasis.
    Schulze-Delrieu K; Summers RW; Finke D
    Lancet; 1981 Jan; 1(8212):159. PubMed ID: 6109839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of prokinetic drugs inhibiting dopaminergic system on gallbladder motility in subjects with duodenal ulcer].
    Szabelska K; Chojnacki J; Grzegorczyk K; Mamos A
    Pol Merkur Lekarski; 1999 Apr; 6(34):188-91. PubMed ID: 10391057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of prokinetic agents on the electrical activity of stomach and duodenum in rats].
    Li F; Zou Y; Huang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 34(7):599-602. PubMed ID: 19648670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
    Miyazawa T; Matsumoto M; Kato S; Takeuchi K
    Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative intestinal atony and vasopressin. A randomized study of the effect of administration of vasopressin on the duration of postoperative intestinal atony].
    Håkansson T; Watt-Boolsen S; Olsen O; Billesbølle P
    Ugeskr Laeger; 1985 Sep; 147(39):3069-70. PubMed ID: 3907073
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of cholecystokinin on postoperative bowel function.
    Frisell J; Magnusson I; Leijonmarck CE; Ihre T
    Acta Chir Scand; 1985; 151(6):557-9. PubMed ID: 3911699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of dopamine and dopamine blockers in gastroduodenal motility.
    Van Nueten JM; Schuurkes JA
    Scand J Gastroenterol Suppl; 1984; 96():89-99. PubMed ID: 6382581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.